Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Bermudez LE and Young LS |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2847644
|
Chan KH et al. |
Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. |
1988 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:2844210
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Araujo FG et al. |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840017
|
Yourassowsky E et al. |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid. |
1988 |
Chemotherapy |
pmid:2843324
|
Ravdin JI and Skilogiannis J |
In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2548442
|
Gladue RP et al. |
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2543276
|
Pascual A et al. |
Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus. |
1990 |
Chemotherapy |
pmid:1963394
|